1 of 4

Prognosis studies vary

julie@glanville.info

1

3/22/2022

Overall prognosis

What is the most likely course for a specific condition?

Prognostic factors

What characteristics are associated with, or predict, a given outcome?

Predictive/prognostic models

Which groups of patients with specific characteristics are more or less likely to experience a given outcome?

Treatment effect modifiers

Which characteristics or factors impact the effectiveness of a treatment?

PROGnosis RESearch Strategy (PROGRESS) series

2 of 4

“PICO”: for overall prognosis

  • Overall prognosis does not explore predictive factors so doesn’t need intervention or comparator
  • POS plus timing

julie@glanville.info

2

3/22/2022

Population – elderly people with varicose veins

Outcome - wound healing

Setting - role or setting

Timeframe/ timing – time to follow-up

3 of 4

PICOTS: prognostic/prediction factors and models

  • PICOT-S suggested by Roque 2020 and Cochrane
  • PICOT-S: What is the best prognostic model to predict overall or progression free survival (outcome) in patients with chronic lymphocytic leukemia (condition)?
  • Sometimes there are named models – so could search on the model name?
  • Study designs for factors - ideally prospective cohort studies, also RCTs
  • Study designs for models – cohort studies, then case control studies, and RCTs

julie@glanville.info

3

3/22/2022

Comparator model/factor

Index - factor/model under review

Population – people with CLL

Outcome - OS or PFS

Timing - when is prediction made and timeframe

Setting/role of the factor/model

4 of 4

What can we reliably search on?

julie@glanville.info

4

3/22/2022

Global prognosis

Prognostic factors

Prognostic models

Population/Condition

Yes

Yes

Yes

Intervention/Prognostic factor

N/A

Yes

Yes

Comparator

N/A

Possibly

Possibly

Setting/Context

Possibly

Possibly

Possibly

Outcome

Yes

Yes

Yes

Timeframe/timing

No

No – consistency issues

No

Study designs

Possibly

Possibly

Possibly

Search filters? How much agreement is there on the eligible study designs?